Point taken. A big snooze, historically. CTDH was a sleepy little stock that the CEO ran like a mom-and-pop hardware store or pharmacy, and no one but their customers knew what the hell cyclodextrins were. The mother of the twin girls whose rare illness is being currently treated with cyclodextrins really opened up a whole new world for the company, and I think the CEO now understands that they can do more than just sell these things like industrial chemicals. They might be able to treat Alzheimer's and HIV with the magic stuff.
Anyway, if my instinct is right, we'll see some news out of them soon that should make clear that it's a whole new ballgame. And the stock's action the past few days seems to agree with my assessment.
News 
Market Data 
Discover 
AI
